Skip to main content
OpenTrials

Clinical trial condition

Head and Neck Neoplasms

Explore clinical trials studying Head and Neck Neoplasms. Study availability and eligibility vary by location and protocol.

1,914 public trials 363 recruiting studies
Refine in advanced search Browse all conditions

Head and Neck Neoplasms trial results

Recruiting

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

NCT07090499

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +50 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
View all 30 locations
View Trial Details
Recruiting

A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1

NCT04534205

Conditions
Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +14 more
Locations
  • California Research Institute Los Angeles, California, United States
  • UCLA Cancer Care Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Yale University New Haven, Connecticut, United States
View all 195 locations
View Trial Details
Recruiting

A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer

NCT04722523

Conditions
Carcinoma, Carcinoma, Squamous Cell, HNSCC, +11 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent only) Commack, New York, United States
View Trial Details
Recruiting

FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC

NCT06788990

Conditions
Bone Diseases, Bone Diseases, Developmental, Camurati-Engelmann Syndrome, +17 more
Locations
  • Site # 0137 Birmingham, Alabama, United States
  • Site #0147 Phoenix, Arizona, United States
  • Site #0107 La Jolla, California, United States
  • Site #0106 Los Angeles, California, United States
View all 203 locations
View Trial Details

Related conditions